EU Panel Likes Nivolumab for Kidney Cancer, Other DrugsEU Panel Likes Nivolumab for Kidney Cancer, Other Drugs

A European advisory committee has recommended extending the indication for immunotherapy to include the treatment of advanced renal cell carcinoma. News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news